These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2231883)

  • 1. Randomized phase II evaluation of carboplatin and CHIP in advanced transitional cell carcinoma of the urothelium. The Eastern Cooperative Oncology Group.
    Trump DL; Elson P; Madajewicz S; Dickman SH; Hahn RG; Harris JE; Vogl SE
    J Urol; 1990 Nov; 144(5):1119-22. PubMed ID: 2231883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma.
    Sonpavde G; Pond GR; Di Lorenzo G; Buonerba C; Rozzi A; Lanzetta G; Necchi A; Giannatempo P; Raggi D; Matsumoto K; Choueiri TK; Mullane S; Niegisch G; Albers P; Lee JL; Kitamura H; Kume H; Bellmunt J
    Clin Genitourin Cancer; 2016 Dec; 14(6):494-498. PubMed ID: 27262369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of carboplatin in patients with advanced germ-cell testicular tumors and transitional cell carcinomas of the urinary tract.
    Akaza H; Hagiwara M; Deguchi N; Kawai T; Satomi Y; Matsuda T; Miki T; Ueda T; Kotake T; Tazaki H
    Cancer Chemother Pharmacol; 1989; 23(3):181-5. PubMed ID: 2466579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.
    Small EJ; Lew D; Redman BG; Petrylak DP; Hammond N; Gross HM; Eastham JA; Crawford ED
    J Clin Oncol; 2000 Jul; 18(13):2537-44. PubMed ID: 10893284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy.
    Galsky MD; Seng S; Camacho LH; Chiorean EG; Mulkerin D; Hong DS; Oh WK; Bajorin DF
    Clin Genitourin Cancer; 2011 Sep; 9(1):27-30. PubMed ID: 21700509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study.
    Vaishampayan UN; Faulkner JR; Small EJ; Redman BG; Keiser WL; Petrylak DP; Crawford ED
    Cancer; 2005 Oct; 104(8):1627-32. PubMed ID: 16138364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of carboplatin or iproplatin in cervical cancer.
    Lira-Puerto V; Silva A; Morris M; Martinez R; Groshen S; Morales-Canfield F; Tenorio F; Muggia F
    Cancer Chemother Pharmacol; 1991; 28(5):391-6. PubMed ID: 1914084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases.
    Soga N; Onishi T; Arima K; Sugimura Y
    Int J Urol; 2007 Sep; 14(9):828-32. PubMed ID: 17760750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma.
    Redman BG; Smith DC; Flaherty L; Du W; Hussain M
    J Clin Oncol; 1998 May; 16(5):1844-8. PubMed ID: 9586899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder.
    Raabe NK; Fossa SD; Parø G
    Br J Urol; 1989 Dec; 64(6):604-7. PubMed ID: 2697452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
    Necchi A; Sonpavde G; Lo Vullo S; Giardiello D; Bamias A; Crabb SJ; Harshman LC; Bellmunt J; De Giorgi U; Sternberg CN; Cerbone L; Ladoire S; Wong YN; Yu EY; Chowdhury S; Niegisch G; Srinivas S; Vaishampayan UN; Pal SK; Agarwal N; Alva A; Baniel J; Golshayan AR; Morales-Barrera R; Bowles DW; Milowsky MI; Theodore C; Berthold DR; Daugaard G; Sridhar SS; Powles T; Rosenberg JE; Galsky MD; Mariani L;
    Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium.
    Dreicer R; Manola J; Roth BJ; See WA; Kuross S; Edelman MJ; Hudes GR; Wilding G
    Cancer; 2004 Apr; 100(8):1639-45. PubMed ID: 15073851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer.
    Johannsen M; Sachs M; Roigas J; Hinke A; Staack A; Loening SA; Schnorr D; Wille AH
    Eur Urol; 2005 Aug; 48(2):246-51. PubMed ID: 15963636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin].
    Ribrag V; Ghnassia M; Théodore C; Ghosn M; Piot G; Beurton D; Cukier J; Droz JP
    J Urol (Paris); 1990; 96(7):373-4. PubMed ID: 2290037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer).
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):375-7. PubMed ID: 3301367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
    Passalacqua R; Lazzarelli S; Donini M; Montironi R; Tambaro R; De Giorgi U; Pignata S; Palumbo R; Ceresoli GL; Del Conte G; Tonini G; Morelli F; Nolè F; Panni S; Rondini E; Guida A; Zucali PA; Doni L; Iezzi E; Caminiti C
    BMC Cancer; 2017 Jul; 17(1):493. PubMed ID: 28724419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of carboplatin and CHIP in patients with metastatic colon carcinoma.
    Asbury RF; Kramer A; Green M; Qazi R; Skeel RT; Haller DG
    Am J Clin Oncol; 1989 Oct; 12(5):416-9. PubMed ID: 2679039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.
    Trump DL; Marsh JC; Kvols LK; Citrin D; Davis TE; Hahn RG; Vogl SE
    Invest New Drugs; 1990; 8 Suppl 1():S91-4. PubMed ID: 2199402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States.
    Pal SK; Hoffman-Censits J; Zheng H; Kaiser C; Tayama D; Bellmunt J
    Eur Urol; 2018 May; 73(5):800-806. PubMed ID: 29478735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of carboplatin in genitourinary cancer. Urological Cooperative Study Group on Carboplatin].
    Niijima T; Tazaki H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2305-11. PubMed ID: 3044277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.